Brief: Nabriva Therapeutics Says Co, Lincoln Park Capital Fund Entered Into Purchase Agreement
27/09/2021 14:22
Sept 27 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS PLC - ON SEPTEMBER 24, CO AND LINCOLN
PARK
CAPITAL FUND ENTERED INTO A PURCHASE AGREEMENT
* NABRIVA THERAPEUTICS PLC - MAY SELL TO LINCOLN PARK UP TO
$23.0
MILLION OF ITS ORDINARY SHARES
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update